These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 4426046

  • 1. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ, Rapp E.
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).
    Cunningham TJ, Nemoto T, Rosner D, Knight E, Taylor S, Rosenbaum C, Horton J, Dao T.
    Cancer Chemother Rep; 1974; 58(5 Pt 1):677-81. PubMed ID: 4138966
    [No Abstract] [Full Text] [Related]

  • 3. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
    Gailani S, Kutcher J.
    J Med; 1973 Jun; 4(4):209-18. PubMed ID: 4520348
    [No Abstract] [Full Text] [Related]

  • 6. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR, Hall R, Brennan TG, Worthy TS.
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group study.
    Tranum BL, Haut A, Rivkin S, Weber E, Quagliana JM, Shaw M, Tucker WG, Smith FE, Samson M, Gottlieb J.
    Cancer; 1975 Apr; 35(4):1148-53. PubMed ID: 1116106
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.